Molecular markers of hemostatic mechanisms--fibrinopeptide a and fibrinopeptide B beta 15-42
Kobayashi, N.
Rinsho Byori. Japanese Journal of Clinical Pathology 37(3): 231-233
1989
ISSN/ISBN: 0047-1860 PMID: 2746916 Document Number: 332339
Document emailed within 1 workday
Related Documents
Tomura, S.; Oono, Y.; Kuriyama, R.; Takeuchi, J. 1985: Plasma concentrations of fibrinopeptide a and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome Archives of Internal Medicine 145(6): 1033-1035Hasegawa, H.; Oguma, Y. 1987: FPA (fibrinopeptide A) and B beta 15-42) Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 70: 233-239
Douglas, J.T.; Blamey, S.L.; Lowe, G.D.; Carter, D.C.; Forbes, C.D. 1985: Plasma beta-thromboglobulin, fibrinopeptide a and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment Thrombosis and Haemostasis 53(2): 235-238
Kawai, Y.; Watanabe, K. 1989: Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex Rinsho Byori. Japanese Journal of Clinical Pathology 37(3): 248-255
Hofmann, V.; Gati, W.P.; Straub, P.W. 1979: Fibrinogen Zurich I: impaired release of fibrinopeptide a Thrombosis and Haemostasis 41(4): 709-713
Murakoshi, T. 1982: Significance of fibrinopeptide a as an indicator for coagulative analysis in thrombotic diseases Hokkaido Journal of Medical Science 57(3): 351-363
Meh, D.A.; Siebenlist, K.R.; Bergtrom, G.; Mosesson, M.W. 1995: Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin Journal of Laboratory and Clinical Medicine 125(3): 384-391
Pogliani, E.M.; Cofrancesco, E.; Salvatore, M.; Boschetti, C.; Cortellaro, M. 1985: High fibrinopeptide a levels modified by heparin in acute nonlymphocytic leukemia Thrombosis and Haemostasis 54(3): 727
Abbasciano, V.; Graziano, L.; Arcudi, D.; Tassinari, D.; Nielsen, I.; Sartori, S. 1991: CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. a contribution to the rationalization of a combined assay Recenti Progressi in Medicina 82(10): 517-519
Idell, S.; Garcia, J.G.; Gonzalez, K.; McLarty, J.; Fair, D.S. 1989: Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease Journal of Rheumatology 16(5): 592-598
Sebestyen, G.; Quillet, P.; Cambres, C. 1990: Determination of fibrinopeptide A (FpA): comparison of an enzymatic method and isotopic method with reference to ventilation-perfusion scintigraphy Annales de Biologie Clinique 48(3): 161-164
Iyano, K.; Kawada, T.; Aiba, M.; Takaba, T. 2004: Correlation of hemostatic molecular markers and morphology of the residual false lumen in chronic aortic dissection Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 10(2): 106-112
Fareed, J.; Bick, R.L.; Squillaci, G.; Walenga, J.M.; Bermes, E.W. 1983: Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders Clinical Chemistry 29(9): 1641-1658
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Wada, H.; Yamamuro, M.; Inoue, A.; Shiku, H.; Sakuragawa, N.; Redl, H.; Peer, G.; Taylor, F.B. 2001: Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC Thrombosis and Haemostasis 86(6): 1489-1494
Ben Salem, M.; Ghanem, N.; Kneissi, T.; Abbal, M.; Dugoujon, J.M.; Ben Chibani, J.; Ellouze, F.; Lefranc, G. 1991: Immunogenetic markers (BF, C2, C4, 21-OH, TNF alpha, TCR beta, Ig) and insulin-dependent diabetes in the Tunisian population: serological and molecular study Annales de Biologie Clinique 49(7): 389-396
Kakunaga, T.; Makino, K.; Kawamoto, T.; Sugiyama, H.; Orita, S.; Niwa, H. 1988: Molecular mechanisms of induction of transcription of beta-actin gene by tumour promoters and serum factors Iarc Scientific Publications 1988(92): 90-101
Takahashi, K.; Hayashi, N.; Kaminogawa, S.; Ra, C. 2006: Molecular mechanisms for transcriptional regulation of human high-affinity IgE receptor beta-chain gene induced by GM-CSF Journal of Immunology 177(7): 4605-4611
Merlini, P.A.; Rossi, M.L.; Bauer, K.A. 2001: Hemostatic markers and prognosis in ischemic heart disease Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(7): 499-501
Vitsenia, M.V.; Noeva, E.A.; Titaeva, E.V.; Dobrovol'skiĭ, A.B. 2004: Effects of exercise on markers of hemostatic activation in young survivors of myocardial infarction Terapevticheskii Arkhiv 76(12): 17-23